C84.Z Category · further specificity required Other mature T/NK-cell lymphomas
ICD-10-CM C84.Z identifies “Other mature T/NK-cell lymphomas” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapter 2: Neoplasms
Code-level instructions
Excludes 18
- angioimmunoblastic T-cell lymphoma (C86.50)
- blastic NK-cell lymphoma (C86.40)
- enteropathy-type T-cell lymphoma (C86.20)
- extranodal NK-cell lymphoma, nasal type (C86.00)
- hepatosplenic T-cell lymphoma (C86.10)
- primary cutaneous CD30-positive T-cell proliferations (C86.60)
- subcutaneous panniculitis-like T-cell lymphoma (C86.30)
- T-cell leukemia (C91.1-)
Note1
If T-cell lineage or involvement is mentioned in conjunction with a specific lymphoma, code to the more specific description.
Inherited instructions
Chapters 2 · Neoplasms (C00-D49)
Note8
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
C81-C96 · Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)
C84 · Mature T/NK-cell lymphomas
Excludes 11
personal history of non-Hodgkin lymphoma (Z85.72)
More specific codes
C84.Z0Other mature T/NK-cell lymphomas, unspecified siteBillable / specificC84.Z1Other mature T/NK-cell lymphomas, lymph nodes of head, face, and neckBillable / specificC84.Z2Other mature T/NK-cell lymphomas, intrathoracic lymph nodesBillable / specificC84.Z3Other mature T/NK-cell lymphomas, intra-abdominal lymph nodesBillable / specificC84.Z4Other mature T/NK-cell lymphomas, lymph nodes of axilla and upper limbBillable / specificC84.Z5Other mature T/NK-cell lymphomas, lymph nodes of inguinal region and lower limbBillable / specificC84.Z6Other mature T/NK-cell lymphomas, intrapelvic lymph nodesBillable / specificC84.Z7Other mature T/NK-cell lymphomas, spleenBillable / specificC84.Z8Other mature T/NK-cell lymphomas, lymph nodes of multiple sitesBillable / specificC84.Z9Other mature T/NK-cell lymphomas, extranodal and solid organ sitesBillable / specificC84.ZAOther mature T/NK-cell lymphomas, in remissionBillable / specificOfficial index references
Official index references (1)
Lymphoma(of) (malignant) (1)
History
Code history
Latest recorded change · FY2025
ChangedUnchanged
FY2025
Effective from
- Code-level rules changed
Other mature T/NK-cell lymphomas
Category — select a more specific code
CDC/NCHS · FY2025All editions (19)
| All editions | Effective from | Code history |
|---|---|---|
| FY2016 | 2015-10-01 | First observed |
| FY2017 | 2016-10-01 | No tabular change |
| FY2018 | 2017-10-01 | No tabular change |
| FY2019 | 2018-10-01 | No tabular change |
| FY2020 | 2019-10-01 | No tabular change |
| FY2020 · April | 2020-04-01 | No tabular change |
| FY2021 | 2020-10-01 | No tabular change |
| FY2021 · 01-01 | 2021-01-01 | No tabular change |
| FY2022 | 2021-10-01 | No tabular change |
| FY2022 · 04-01 | 2022-04-01 | No tabular change |
| FY2023 | 2022-10-01 | No tabular change |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | No tabular change |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | Code-level rules changed |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
Explore the more specific codes in this category. Reference checks do not establish clinical appropriateness or guarantee reimbursement.